| YARTEMLEASSURE PATIENT SUPPORT PROGRAM Omeros Corporation 2264467 24 Nov 2021 | Cancelled: Cancelled at the request of IB | Printed publications in the nature of brochures, pamphlets, newsletter... Class 016 Class 016 Paper Goods and Printed Material Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support. Class 035 Class 035 Advertising, Business & Retail Services Advertising and promotional services to promote awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals; benefits verification in the nature of insurance claims administration. Class 036 Insurance & Financial Services Providing financial information regarding medical benefits and reimbursements available for medical expenses related thereto via a website; and insurance services; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders.
Class 041 Education and Entertainment Services Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions. | |